Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;95(9):e2937.
doi: 10.1097/MD.0000000000002937.

Acinetobacter seifertii Isolated from China: Genomic Sequence and Molecular Epidemiology Analyses

Affiliations

Acinetobacter seifertii Isolated from China: Genomic Sequence and Molecular Epidemiology Analyses

Yunxing Yang et al. Medicine (Baltimore). 2016 Mar.

Abstract

Clinical infections caused by Acinetobacter spp. have increasing public health concerns because of their global occurrence and ability to acquire multidrug resistance. Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex encompasses A. calcoaceticus, A. baumannii, A. pittii (formerly genomic species 3), and A nosocomial (formerly genomic species 13TU), which are predominantly responsible for clinical pathogenesis in the Acinetobacter genus. In our previous study, a putative novel species isolated from 385 non-A. baumannii spp. strains based on the rpoB gene phylogenetic tree was reported. Here, the putative novel species was identified as A. seifertii based on the whole-genome phylogenetic tree. A. seifertii was recognized as a novel member of the ACB complex and close to A. baumannii and A. nosocomials. Furthermore, we studied the characteristics of 10 A. seifertii isolates, which were distributed widely in 6 provinces in China and mainly caused infections in the elderly or children. To define the taxonomic status and characteristics, the biochemical reactions, antimicrobial susceptibility testing, pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and whole-genome sequence analysis were performed. The phenotypic characteristics failed to distinguish A. serfertii from other species in the ACB complex. Most of the A. seifertii isolates were susceptible to antibiotics commonly used for nosocomial Acinetobacter spp. infections, but one isolate (strain A362) was resistant to ampicillin/sulbactam, ceftazidime and amikacin. The different patterns of MLST and PFGE suggested that the 10 isolates were not identical and lacked clonal relatedness. Our study reported for the first time the molecular epidemiological and genomic features of widely disseminated A. seifertii in China. These observations could enrich the knowledge of infections caused by non-A. baumannii and may provide a scientific basis for future clinical treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Phylogenetic relationship between 3 strains of putative novel species and other Acinetobacter spp. (A) Whole-genome phylogenetic tree of the 3 strains and other sequenced Acinetobacter spp. genomes. aIndicates the 3 strains that were chosen for whole-genome sequencing in this study. (B) Genome comparison between A. seifertii, A. baumannii, and A. nosocomials. The numbers in the Venn diagram represent the shared genes between the compared strains. Data outside the Venn diagram represent average amino acid identity between the adjacent strains ± standard deviation.
FIGURE 2
FIGURE 2
Molecular epidemiology characteristics of 10 A. seifertii isolates. (A) Minimum spanning tree analysis of 10 A. seifertii isolates based on multilocus sequence typing data. Each circle represents independent sequence type (ST). The lines connecting the circles indicate the relationship between different STs. Different types of lines represent a difference in 3 alleles (dashed lines) and ≥4 alleles (dotted lines). (B) Pulsed field gel electrophoresis analysis for the 10 A. seifertii isolates (variation within 3 bands indicates the same clone).

Similar articles

Cited by

References

    1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–582. - PMC - PubMed
    1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939–951. - PubMed
    1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148–165. - PMC - PubMed
    1. Biedenbach DJ, Bouchillon SK, Hoban DJ, et al. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagnost Microbiol Infect Dis 2014; 79:463–467. - PubMed
    1. Kuo SC, Chang SC, Wang HY, et al. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis 2012; 12:200. - PMC - PubMed

Publication types

Substances